From BioHealth Investor
Biotechnology
DYAX CORP [DYAX] +9.51%
FERMAVIR PHARMACEUTL [FMVR.OB] +8.57%
ZIOPHARM ONCOLOGY IN [ZIOP] +7.30%
ALNYLAM PHARMACEUT [ALNY] +6.75%
GENITOPE CORPORATION [GTOP] +5.85%
Diagnostic Substances
EPICEPT CORPORATION [EPCT] +11.76%
GENELABS TECH INC [GNLB] +5.00%
DIGENE CP [DIGE] +4.09%
MONOGRAM BIOSCIENCES [MGRM] +3.51%
MYRIAD GENETICS [MYGN] +3.46%
Drug Delivery
QUIGLEY CORP THE [QGLY] +5.30%
NOVADEL PHARMA INC [NVD] +5.00%
NEKTAR THERAPEUTIC [NKTR] +3.36%
GENEREX BIOTECH CORP [GNBT] +3.30%
BIOPROGRESS PLC [BPRG] +1.81%
Drug Manufacturers
ELITE PHARMA INC [ELI] +7.85%
DUSA PHARM INC [DUSA] +4.99%
CUBIST PHARMACEUTC [CBST] +4.87%
ALLOS THERAPEUTICS [ALTH] +4.61%
ARENA PHARMACEUTIC [ARNA] +3.63%
Medical Appliances & Equipment
MEDICAL ACTION IND [MDCI] +16.22%
UROLOGIX INC [ULGX] +11.18%
MEDICALCV INC [MCVI.OB] +10.87%
REGENERATION TECH [RTIX] +10.57%
VISION SCIENCES IN [VSCI] +6.45%
Medical Instruments & Supplies
ENCISION INC [ECI] +12.58%
MILESTONE SCIENTIFIC [MLSS.OB] +10.26%
BIOMIMETIC THERAPEUT [BMTI] +7.11%
PRO-DEX INC NEW [PDEX] +7.09%
CHINA MEDICAL TECH [CMED] +6.31%
Medical Laboratories & Research
PHARM PROD DEV [PPDI] +4.17%
OSI PHARMACEUTIC [OSIP] +1.61%
AETERNA ZENTARIS [AEZS] +1.25%
ERESEARCHTECHNOLOG [ERES] +0.98%
ALLIANCE IMAGING INC [AIQ] +0.85%
http://www.biohealthinvestor.com/
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.